[Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure].
作者信息
Kayanakis J G, Fauvel J M, Giraud P, Boccalon H, Puel J, Cassagneau B, Bounhoure J P